HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neutrogena skin care

This article was originally published in The Rose Sheet

Executive Summary

ProCyte licenses copper peptide patents to Neutrogena for development of "skin health" products, ProCyte announces. The copper peptide technology has been shown to have a "very positive effect" on fine lines/wrinkles, and aids in collagen and elastin formation, the supplier claims. Neutrogena reviewed two ProCyte complexes for hair and skin care, but decided not to pursue the hair care technology. ProCyte is in similar licensing agreement with Osmotics for the prestige market
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS008023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel